United States
Chemorefractory, Diffuse Large B-cell Lymphoma (DLBCL), Bruton Tyrosine Kinase Inhibitor (BTK), Ibrutinib, Activated B-cell (ABC), Germinal Center B-cell (GCB), B-cell receptor (BCR)